National trends in radiation dose escalation for glioblastoma
Radiation Oncology Journal. 2019;37(1):13-21 
Pulsed Low-dose-rate Versus Standard Irradiation in Orthotopic Glioblastoma Multiforme: Dose-Escalation, Functional Imaging, and the Small Animal Radiation Research Platform
International Journal of Radiation Oncology*Biology*Physics. 2012;84(3):S696
993 Poster Novel approaches for dose escalation in radiotherapy of glioblastoma: first clinical experience
Radiotherapy and Oncology. 2002;64:S292
Feasibility of Extreme Dose Escalation for Glioblastoma Multiforme Using 4π Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics. 2014;90(1):S109
A Phase I Dose per Fraction Escalation Study of Hypofractionated Intensity-modulated Radiation Therapy with Temozolomide Chemotherapy for Patients with Newly Diagnosed Glioblastoma
International Journal of Radiation Oncology*Biology*Physics. 2009;75(3):S103
Phase 1 TITE-CRM Dose Escalation Study of Concurrent Temozolomide and Intensity Modulated Radiation Therapy in Newly Diagnosed Glioblastoma Multiforme
International Journal of Radiation Oncology*Biology*Physics. 2009;75(3):S124
NTCP Modeling of Dose-escalation Hypofractionated Stereotactic Radiation Therapy (HFSRT) for Patients With Subtotally Resected (STR) Newly Diagnosed Glioblastoma Multiforme (GBM)
International Journal of Radiation Oncology*Biology*Physics. 2012;84(3):S272
A Phase I dose escalation trial of motexafin gadolinium (gadolinium texaphyrin, xcytrinR)as a radiation sensitizer in patients with newly diagnosed glioblastoma multiforme
International Journal of Radiation Oncology*Biology*Physics. 2001;51(3):205
Towards biologically conformal radiation therapy (BCRT): Selective IMRT dose escalation under the guidance of spatial biology distribution
Medical Physics. 2005;32(6Part1):1473-1484
Dose-escalation strategies which use subgroup information
Pharmaceutical Statistics. 2018;